Drews-Botsch Carolyn D, Cotsonis George, Celano Marianne, Zaidi Jaffer, Hartmann E Eugenie, Lambert Scott R
Department of Global and Community Health, College of Public Health, George Mason University, Fairfax, Virginia.
Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Ophthalmology. 2025 Apr;132(4):389-396. doi: 10.1016/j.ophtha.2024.11.005. Epub 2024 Nov 9.
The goal of these analyses is to provide evidence that can help parents and healthcare providers determine whether or not to continue occlusion therapy once a reliable measure of optotype acuity can be obtained in children who are born with a unilateral congenital cataract.
Data from the Infant Aphakia Treatment Study (IATS) are used in a cohort design.
A total of 105 children who participated in the IATS and did not have a vision-threatening adverse event.
We assessed the relationship between visual acuity (VA) at age 10.5 years and average daily hours of patching reported by caregivers on quarterly 48-hour recall interviews and annual 7-day patching diaries obtained between 48 and 60 months of age.
Monocular VA was assessed at the clinic visit closest to 48 months of age using the Amblyopia Treatment Study HOTV protocol. Final VA was measured at age 10.5 years using the electronic ETDRS testing protocol.
Visual acuity measurements obtained at age 4 years were reliable, with a single-measure intraclass correlation coefficient of 0.83 (95% confidence interval [CI], 0.78-0.88), and predictive of those obtained at age 10.5 years (r = 0.83; P < 0.01). In 38% (n = 40) of the children, the VA measured at age 10.5 years was within ±0.10 logarithm of the minimum angle of resolution of the measurement obtained at age 4 years. The amount of patching that was received between the fourth and fifth birthdays was unrelated to changes in VA.
These analyses suggest that optotype acuity measures obtained early in the fifth year of life are reliable and predictive of final visual outcomes. Additionally, our results suggest that less-aggressive patching protocols, or discontinuing patching altogether, may be justified in some children, particularly those with poor vision, once optotype acuity can be measured. However, the potential impact of latent nystagmus on uniocular VA measurement and the effect of patching on the child's quality of life, family relationships, and binocular visual field need to be considered before discontinuing occlusion therapy.
FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
这些分析的目的是提供证据,以帮助父母和医疗保健提供者确定,对于患有单侧先天性白内障的儿童,一旦能够获得可靠的视标视力测量结果,是否应继续进行遮盖治疗。
婴儿无晶状体治疗研究(IATS)的数据用于队列设计。
共有105名参加IATS且未发生威胁视力的不良事件的儿童。
我们评估了10.5岁时的视力(VA)与照顾者在每季度48小时回忆访谈中报告的平均每日遮盖小时数之间的关系,以及在48至60个月大时获得的年度7天遮盖日记。
在最接近48个月大的门诊就诊时,使用弱视治疗研究HOTV方案评估单眼视力。在10.5岁时使用电子ETDRS测试方案测量最终视力。
4岁时获得的视力测量结果可靠,单次测量组内相关系数为0.83(95%置信区间[CI],0.78 - 0.88),并且可以预测10.5岁时获得的结果(r = 0.83;P < 0.01)。在38%(n = 40)的儿童中,10.5岁时测量的视力在4岁时获得的测量结果的最小分辨角对数的±0.10范围内。在第四个生日和第五个生日之间接受的遮盖量与视力变化无关。
这些分析表明,在生命的第五年早期获得的视标视力测量结果是可靠的,并且可以预测最终的视力结果。此外,我们的结果表明,对于一些儿童,尤其是那些视力较差的儿童,一旦可以测量视标视力,采用不太积极的遮盖方案或完全停止遮盖可能是合理的。然而,在停止遮盖治疗之前,需要考虑潜在的眼球震颤对单眼视力测量的影响以及遮盖对儿童生活质量、家庭关系和双眼视野的影响。
在本文末尾的脚注和披露中可能会找到专有或商业披露信息。